The safety of <font color="blue">whey_2</font> <font color="blue">protein_2</font> <font color="blue">concentrate_2</font> <font color="blue">derived_2</font> <font color="blue">from_2</font> <font color="blue">the_2</font> <font color="blue">milk_2</font> <font color="blue">of_2</font> <font color="blue">cows_2</font> <font color="blue">immunized_1</font> <font color="blue">against_1</font> <font color="blue">Clostridium_1</font> <font color="blue">difficile_1</font> <font color="blue">._1</font> 
<br>
<br> <font color="blue">A_1</font> <font color="blue">whey_2</font> <font color="blue">protein_2</font> <font color="blue">concentrate_2</font> <font color="blue">prepared_2</font> <font color="blue">from_2</font> <font color="blue">the_2</font> <font color="blue">milk_2</font> <font color="blue">of_2</font> <font color="blue">cows_2</font> <font color="blue">that_1</font> <font color="blue">have_1</font> <font color="blue">been_1</font> <font color="blue">immunized_1</font> <font color="blue">against_1</font> <font color="blue">Clostridium_1</font> <font color="blue">difficile_1</font> <font color="blue">(_1</font> <font color="blue">C._1</font> <font color="blue">difficile_1</font> <font color="blue">)_1</font> <font color="blue">and_1</font> <font color="blue">its_1</font> <font color="blue">toxins_1</font> <font color="blue">,_1</font> <font color="blue">toxin_1</font> <font color="blue">A_1</font> <font color="blue">and_1</font> <font color="blue">toxin_1</font> <font color="blue">B_1</font> <font color="blue">,_1</font> is produced for use as a medical food for the dietary management of patients with C. difficile - associated diarrhea ( CDAD ) to prevent a relapse of the infection . The safety of <font color="blue">anti_2</font> <font color="blue">-_2</font> <font color="blue">C._2</font> <font color="blue">difficile_2</font> <font color="blue">whey_2</font> <font color="blue">protein_2</font> <font color="blue">concentrate_2</font> <font color="blue">(_2</font> <font color="blue">anti_3</font> <font color="blue">-_3</font> <font color="blue">CD_3</font> <font color="blue">WPC_3</font> <font color="blue">)_3</font> <font color="blue">is_1</font> supported by analytical data comparing the composition of <font color="blue">raw_2</font> <font color="blue">milk_2</font> <font color="blue">from_2</font> <font color="blue">immunized_3</font> <font color="blue">cows_3</font> <font color="blue">versus_2</font> <font color="blue">that_2</font> <font color="blue">from_2</font> <font color="blue">non_3</font> <font color="blue">-_3</font> <font color="blue">immunized_3</font> <font color="blue">cows_3</font> <font color="blue">,_3</font> and the composition of <font color="blue">anti_3</font> <font color="blue">-_3</font> <font color="blue">CD_3</font> <font color="blue">WPC_3</font> <font color="blue">versus_3</font> <font color="blue">that_3</font> <font color="blue">of_3</font> <font color="blue">regular_3</font> <font color="blue">whey_3</font> <font color="blue">protein_3</font> <font color="blue">concentrate_3</font> <font color="blue">._3</font> Additionally , a prospective clinical study was conducted in 77 patients with CDAD to demonstrate the safety of consuming <font color="blue">anti_2</font> <font color="blue">-_2</font> <font color="blue">CD_2</font> <font color="blue">WPC_2</font> to prevent relapse of the infection . This study , which included adverse event monitoring , physical examinations , and extensive hematological and biochemical assessments , showed that <font color="blue">anti_2</font> <font color="blue">-_2</font> <font color="blue">CD_2</font> <font color="blue">WPC_2</font> is safe to consume by patients with CDAD . The available analytical and clinical evidence demonstrate that <font color="blue">anti_2</font> <font color="blue">-_2</font> <font color="blue">CD_2</font> <font color="blue">WPC_2</font> is safe for use by individuals with CDAD , under the described conditions of use .